The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.
Open accessAbstract
Systemic infusion of low concentrations of tumor necrosis factor/cachectin (TNF) into mice that bear TNF-sensitive tumors leads to activation of coagulation, fibrin formation, and occlusive thrombosis exclusively within the tumor vascular bed. To identify mechanisms underlying the localization of this vascular procoagulant response, a tumor-derived polypeptide has been purified to homogeneity from supernatants of murine methylcholanthrene A-induced fibrosarcomas that induces endothelial tissue factor synthesis and expression (half-maximal response at approximately 300 pM), and augments the procoagulant response to TNF in a synergistic fashion. This tumor-derived polypeptide was identified as the murine homologue of vascular permeability factor (VPF) based on similar mobility on SDS-PAGE, an homologous NH2-terminal amino acid sequence, and recognition by a monospecific antibody to guinea pig VPF. In addition, VPF was shown to induce monocyte activation, as evidenced by expression of tissue factor. Finally, VPF was shown to induce monocyte chemotaxis across collagen membranes and endothelial cell monolayers. Taken together, these results indicate that VPF can modulate the coagulant properties of endothelium and monocytes, and can promote monocyte migration into the tumor bed. This suggests one mechanism through which tumor-derived mediators can alter properties of the vessel wall.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Matsudaira, P. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61070-1 · Cited by 4,950
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Folkman, J., & Klagsbrun, M. (1987) · Science · doi:10.1126/science.2432664 · Cited by 3,491
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF
Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., & Connolly, D. T. (1989) · Science · doi:10.1126/science.2479987 · Cited by 2,061
Self-citationOld, L. J. (1985) · Science · doi:10.1126/science.2413547 · Cited by 1,895
Cachectin and tumour necrosis factor as two sides of the same biological coin
Beutler, B., & Cerami, A. (1986) · Nature · doi:10.1038/320584a0 · Cited by 1,647
Cited by
Items 101–118 of 118
Multiple Developmental Roles of VEGF Suggested by a LacZ-Tagged Allele
Miquerol, L., Gertsenstein, M., Harpal, K., Rossant, J., & Nagy, A. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9355 · Cited by 281
Breier, G., Clauss, M., & Risau, W. (1995) · Developmental Dynamics · doi:10.1002/aja.1002040303 · Cited by 280
Self-citationTsai, J.-C., Goldman, C. K., & Gillespie, G. Y. (1995) · Journal of Neurosurgery · doi:10.3171/jns.1995.82.5.0864 · Cited by 278
Signaling via Vascular Endothelial Growth Factor Receptors
Petrova, T. V., Makinen, T., & Alitalo, K. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4707 · Cited by 277
Developmental Control of Blood Cell Migration by the Drosophila VEGF Pathway
Cho, N. K., Keyes, L., Johnson, E., Heller, J., Ryner, L., Karim, F., & Krasnow, M. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00676-1 · Cited by 276
Angiogenic factors stimulate mast-cell migration
Gruber, B., Marchese, M., & Kew, R. (1995) · Blood · doi:10.1182/blood.v86.7.2488.2488 · Cited by 275
Vascular endothelial growth factor and endometriotic angiogenesis
McLaren, J. (2000) · Human Reproduction Update · doi:10.1093/humupd/6.1.45 · Cited by 269
Cohen, T., Gitay-Goren, H., Sharon, R., Shibuya, M., Halaban, R., Levi, B.-Z., & Neufeld, G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.19.11322 · Cited by 269
Vascular permeability factor mRNA and protein expression in human kidney
Brown, L. F., Berse, B., Tognazzi, K., Manseau, E. J., Van De Water, L., Senger, D. R., Dvorak, H. F., & Rosen, S. (1992) · Kidney International · doi:10.1038/ki.1992.441 · Cited by 267
Otani, A., Takagi, H., Suzuma, K., & Honda, Y. (1998) · Circulation Research · doi:10.1161/01.res.82.5.619 · Cited by 266
RhoA/ROCK signaling is essential for multiple aspects of VEGF‐mediated angiogenesis
Bryan, B. A., Dennstedt, E., Mitchell, D. C., Walshe, T. E., Noma, K., Loureiro, R., Saint‐Geniez, M., Campaigniac, J., Liao, J. K., & Patricia, D. A. (2010) · The FASEB Journal · doi:10.1096/fj.09-145102 · Cited by 261
Platelets and cancer angiogenesis nexus
Wojtukiewicz, M. Z., Sierko, E., Hempel, D., Tucker, S. C., & Honn, K. V. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9673-1 · Cited by 257
Expression of vascular endothelial growth factor in experimental choroidal neovascularization
Ishibashi, T., Hata, Y., Yoshikawa, H., Nakagawa, K., Sueishi, K., & Inomata, H. (1997) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/bf00941723 · Cited by 256
Functional Upregulation of the Vascular Endothelial Growth Factor Receptor KDR by Hypoxia
Waltenberger, J., Mayr, U., Pentz, S., & Hombach, V. (1996) · Circulation · doi:10.1161/01.cir.94.7.1647 · Cited by 253
Yoshida, A., Anand-apte, B., & Zetter, B. R. (1996) · Growth Factors · doi:10.3109/08977199609034566 · Cited by 252
Yu, J. L., & Rak, J. W. (2003) · Breast Cancer Research · doi:10.1186/bcr573 · Cited by 146
“However, in addition to these direct effects on endothelial cells, VEGF also stimulates monocyte migration through VEGFR-1 [32], which is expressed on monocytes and”
BackgroundShen, W. Y., Yu, M. J. T., Barry, C. J., Constable, I. J., & Rakoczy, P. E. (1998) · British Journal of Ophthalmology · doi:10.1136/bjo.82.9.1063 · Cited by 140
Vuorela, P., Andersson, S., Carpén, O., Ylikorkala, O., & Halmesmäki, E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.5.1196 · Cited by 50
“Because we showed VEGFR-1 and VEGFR-2 to be present in the intestinal luminal epithelium, and because VEGF has been shown to promote monocyte migration (13), it is tempting to speculate whether VEGF may be involved in the host defense mechanisms of the newborn intestine, perhaps in concert with the various other cytok…”
Background
Metadata
- Authors
- Clauss, M., Gerlach, M., Gerlach, H., Brett, J., Wang, F., Familletti, P. C., Pan, Y. C., Olander, J. V., Connolly, D. T., & Stern, D.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1990-12-01
- Volume
- 172
- Issue
- 6
- Pages
- 1535-1545
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2121594719
- Cited by
- 835
- References
- 27
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.